Case reports of severe dolutegravir-related depression
Few people with HIV starting raltegravir and dolutegravir change therapy because of side-effects
People treated with atazanavir had lower risk of stroke and heart attack
Researchers say rule out depression, anxiety, unemployment and other stresses before blaming cognitive impairment for everyday difficulties
Risk score can identify which HIV-positive people with controlled viral load are at greatest risk of neurocognitive decline
Switching from efavirenz to lopinavir/ritonavir has no meaningful impact on neurological function, says UK study
Studies look at brain and cognitive changes in people with HIV as they age
Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk
